- Global Pharma News & Resources


Research & Development

Helsinn has become one of the world’s leading cancer care and rare diseases companies, with a comprehensive portfolio of products and therapies helping to improve the lives of patients all around the world. We work with a host of longstanding worldwide partners who share our vision and values, with a unique business model combining integrated early- and late-stage licensing programs to complement our own drug discovery and development.